Mandibular Advancement Clear Aligner Treatment in Juvenile Idiopathic Arthritis Subjects
Short-term and Long-term Evaluation of Three-dimensional Morphological Condylar and Mandibular Changes in Patients Affected by Juvenile Idiopathic Arthritis Treated With Mandibular Advancement Clear Aligner. A Prospective Controlled Study
1 other identifier
interventional
50
1 country
1
Brief Summary
There is currently no information on how mandibular advancement therapy could influence three-dimensionally the condylar and mandibular morphology in growing patients affected by Juvenile Idiopathic Arthritis (JIA). Therefore, the aim is to assess the three-dimensional morphological mandibular changes produced by the Invisalign® Mandibular Advancement (MA) (Align Technology, San José, CA, USA) in growing subjects affected by juvenile idiopathic arthritis with unilateral and bilateral JIA and to compare them with not-JIA control subjects
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2022
CompletedFirst Posted
Study publicly available on registry
July 20, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedJuly 20, 2022
July 1, 2022
1.3 years
July 14, 2022
July 19, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Improvement of the facial profile
Clinical evaluation in vivo (binary outcome yes/no)
12 months
Mandibular growth achievement
Measured on CBCT scans (increase in mm of the mandibular length, superimposition of the 3D reconstruction of the condyles)
12 months
Presence of inflammation during active phase of mandibular advancement
To monitoring TMJ inflammation during the active phase of treatment comparing the MRI taken before the beginning of therapy with those taken as controls every six months until the end of treatment and to evaluate patient's reported outcomes regarding treatment with mandibular advancement both in JIA and in the healthy control group
12 months
Discomfort during active phase
Discomfort reported on a questionnaire during all the active phase of treatment recorded every 6 month (VAS scale, pain min-max 0-100)
6 months
Discomfort during active phase
Discomfort reported on a questionnaire during all the active phase of treatment recorded every 6 month (VAS scale, pain min-max 0-100)
12 months
Study Arms (2)
Healthy subjects
ACTIVE COMPARATORHealthy patients that will serve as controls will recruited having the same demographic characteristics of the experimental group i.e., age, sex, vertebral maturation stage and the same cranio-facial features, skeletal class II, class II division 1 malocclusion, mandibular retrognathia, normal/hyperdivergent growth pattern.
JIA subjects
EXPERIMENTALYoung people aged from 10 to 14 years old with skeletal class II, class II division 1 malocclusion, mandibular retrognathia, normal/hyperdivergent growth pattern, and affected by juvenile idiopathic arthritis
Interventions
Intervention orthodontic - mandibular advancement: mandibular retrognathia correction with a mandibular advancement using a step-wise approach with clear aligner.
Eligibility Criteria
You may not qualify if:
- Previous orthodontic or orthopedic treatment with any type of intervention (to avoid confounding factors related to previous treatment)
- Patients with severe transverse dental or skeletal discrepancies
- Syndromes, orofacial cleft, or other special needs, except for Juvenile idiopathic arthritis
- Missing teeth (to avoid confounding factors related to anchorage loss due to the absence or early extraction of permanent teeth)
- Poor oral health that precludes orthodontic treatment (presence of caries, active white spots or periodontal diseases)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Genovalead
- University of Milan - Prof. Maspero Cinziacollaborator
- University of Milan - Dr. Abate Andreacollaborator
Study Sites (1)
Università di Milano, Ospedale maggiore Policlincio, IRCCS Cà Granda
Milan, Itali, 20100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 14, 2022
First Posted
July 20, 2022
Study Start
October 1, 2022
Primary Completion
January 1, 2024
Study Completion
January 1, 2025
Last Updated
July 20, 2022
Record last verified: 2022-07